Thermosome

TwoStep Therapeutics

The company develops peptide-drug conjugates and targeted therapies for patients with solid tumours.

THERAtRAME

The company develops small molecule inhibitors targeting tRNA epitranscriptomics to treat resistant and immune-refractory cancers for patients with limited therapeutic options.

Neobe

The company develops engineered microbial biotherapeutics designed to disrupt the microenvironment of solid tumours for cancer patients receiving immunotherapy.

DualTPharma

This company develops bacteria-based drug delivery systems to transport immunotherapies into solid tumours for cancer patients.

Theraport

Theraport develops engineered exosomes to facilitate the targeted delivery of drugs and genetic medicines for patients with complex diseases.

Asgard Therapeutics

The company develops gene therapies that reprogramme cancer cells into immune cells for patients with various types of tumours.

Actithera Group

This company develops radioligand therapies to treat cancer patients by delivering radiation directly to solid tumours while sparing healthy tissue.

Vivere Oncotherapies

This company develops engineered cancer immunotherapies to help the immune systems of patients with solid tumours detect and destroy malignant cells.